Journal article
The landscape of targeted immune responses in the HIV-1 vaccine field.
- Abstract:
- HIV-1 vaccine development is rapidly advancing numerous diverse vaccine candidates based on a variety of hypotheses about what contributes to protective HIV-1 immunity (1–3). It is common to differentiate vaccine candidates as being antibody-based, T-cell-based, or both, which is a useful classification, but it does not provide enough granularity to capture the multiple complementing hypotheses regarding the contribution of particular immune responses to protection against HIV-1
- Publication status:
- Published
- Peer review status:
- Peer reviewed
Actions
Access Document
- Files:
-
-
(Preview, Accepted manuscript, pdf, 192.1KB, Terms of use)
-
- Publisher copy:
- 10.1089/AID.2016.0120
Authors
- Publisher:
- Mary-Ann Liebert
- Journal:
- AIDS Research and Human Retroviruses More from this journal
- Volume:
- 32
- Issue:
- 10-11
- Pages:
- 944-946
- Publication date:
- 2016-06-01
- Acceptance date:
- 2016-05-13
- DOI:
- EISSN:
-
1931-8405
- ISSN:
-
0889-2229
- Language:
-
English
- Pubs id:
-
pubs:630928
- UUID:
-
uuid:16b4f8a8-46b6-4a62-ae97-13e21328ffcf
- Local pid:
-
pubs:630928
- Source identifiers:
-
630928
- Deposit date:
-
2016-07-04
- ARK identifier:
Terms of use
- Copyright holder:
- Jeffrey T Safrit, et al
- Copyright date:
- 2016
- Notes:
- © Jeffrey T. Safrit, et al., 2016; Published by Mary Ann Liebert, Inc. This Open Access article is distributed under the terms of the Creative Commons Attribution Noncommercial License (http://creativecommons.org/licenses/by-nc/4.0/) which permits any noncommercial use, distribution, and reproduction in any medium, provided the original author(s) and the source are credited.
If you are the owner of this record, you can report an update to it here: Report update to this record